Cubist Systematic Strategies, LLC - ACUMEN PHARMACEUTICALS INC ownership

ACUMEN PHARMACEUTICALS INC's ticker is ABOS and the CUSIP is 00509G209. A total of 66 filers reported holding ACUMEN PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.12 and the average weighting 0.2%.

Quarter-by-quarter ownership
Cubist Systematic Strategies, LLC ownership history of ACUMEN PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$63,088
+4.3%
13,116
-12.0%
0.00%
Q1 2023$60,490
-37.7%
14,899
-17.2%
0.00%
-100.0%
Q4 2022$97,157
-57.8%
17,992
-21.6%
0.00%0.0%
Q3 2022$230,000
+105.4%
22,942
-4.0%
0.00%0.0%
Q2 2022$112,000
+433.3%
23,908
+343.8%
0.00%
Q1 2022$21,000
-73.1%
5,387
-53.3%
0.00%
-100.0%
Q4 2021$78,00011,5450.00%
Other shareholders
ACUMEN PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Sands Capital Ventures, LLC 3,417,075$14,180,8614.20%
Knollwood Investment Advisory, LLC 1,628,510$6,758,3173.16%
Altium Capital Management LP 650,000$2,697,5001.41%
RA Capital Management 14,932,063$61,968,0611.22%
GREAT POINT PARTNERS LLC 1,074,101$4,457,5190.81%
Boxer Capital, LLC 2,206,983$9,158,9790.49%
Deep Track Capital, LP 2,513,044$10,429,1330.40%
Parkman Healthcare Partners LLC 499,814$2,074,2280.38%
Rock Springs Capital Management LP 2,812,579$11,672,2030.31%
Ghost Tree Capital, LLC 150,000$622,5000.20%
View complete list of ACUMEN PHARMACEUTICALS INC shareholders